The Future of Pharma Pricing, Access, and Global Market Complexity

About this episode

The episode discusses the complexities of pharmaceutical pricing and access in the U.S. and globally, featuring insights from experts at Model N.

Send us Fan Mail Jesse Mendelsohn and Michael Grosberg from Model N discuss why U.S. pricing complexity is spreading globally, the collapse of the PBM rebate model, what's really driving the pharmaceutical manufacturing boom, and why direct-to-consumer discount programs won't solve America's drug access problem. 00:00 Introduction to Life Science Success Podcast 00:34 Pressing Issues in Pharmaceutical Manufacturing 00:51 Introducing the Experts from Model N 03:08 Understanding International ...

People in this episode

Host: Don Davis PhD, MBA

Guests: Jesse Mendelsohn, Michael Grosberg

Topics covered

• pharmaceutical pricing
• drug access
• global market complexity
• pharmaceutical manufacturing
• direct-to-consumer programs

Keywords

• pharmaceutical pricing
• drug access
• PBM rebate model
• manufacturing boom
• discount programs

Mentioned in this episode

Organizations: Model N

More episodes of Life Science Success

• Transforming Pharma Regulatory Operations with Megha Sinha · May 1, 2026 · 45 min
• Breaking Down Silos with Ian Crone: Regulatory Data, IDMP, and AI Readiness in Life Sciences · April 14, 2026 · 49 min
• Inspection Readiness and Quality Systems with Jennifer Vavala · April 9, 2026 · 41 min
• Dean Erhardt: Pharma Strategy, Distribution & Commercial Growth · April 2, 2026 · 39 min
• Align, Apply, Adapt: Building Lasting Compliance with Troy Fugate · October 20, 2025 · 42 min
• RNA Secrets Unveiled: Byron Purse's Biotech Breakthrough Journey · October 11, 2025 · 44 min